留言e-mail: ok7260678@gmail.com,Goole Talk me

博元婦產科不孕症試管嬰兒中心:蔡鋒博醫師,陳昭雯醫師

2009年1月20日 星期二

探討屢次試管嬰兒著床失敗的原因及其治療

探討屢次試管嬰兒著床失敗的原因及其治療


http://humrep.oxfordjournals.org/cgi/content/abstract/21/12/3036


http://humrep.oxfordjournals.org/cgi/content/full/21/12/3036




Treatment of the embryos
Preimplantation genetic screening
Patients with RIF develop a high percentage of chromosomally abnormal embryos that fail to implant despite regular morphology and developmental rate. Using preimplantation genetic screening (PGS) and selecting chromosomally normal embryos for replacement significantly increased the implantation rates in RIF when 3–8 chromosomes were analysed (Munne, 2003; Pehlivan et al., 2003; Wilding et al., 2004). Taranissi et al. (2005) have shown that PGS for chromosomes 13, 16, 18, 21 and 22 was associated with improved outcome (PR of 43% and delivery rate of 32%) in young women with RIF. However, Caglar et al. (2005) reviewing the literature on PGS in RIF concluded that the data in the literature did not provide firm evidence that patients with RIF will benefit from PGS. They state that PGS can be useful to clarify the reason for recurrent failures.
Wilton et al. (2003) showed that CGH was able to identify many chromosomal abnormalities that would have been missed if those cells had been analysed by FISH. The clinical pregnancy and implantation rates were 11 and 7% for embryos analysed by FISH and 21 and 15% for embryos analysed by CGH. However, CGH remains technically challenging and, in its current form, is likely to be performed in only few laboratories.



Perform your original search, Investigation and treatment of repeated implantation failure following IVF-ET?Human Reproduction?2006, Vol. 21, No. 12. PP. 3036-3043, in Hum. Reprod. Search

Hum. Reprod. Advance Access originally published online on August 12, 2006
Human Reproduction 2006 21(12):3036-3043; doi:10.1093/humrep/del305
This Article

Full Text
FREE Full Text (PDF )
All Versions of this Article:
21/12/3036 most recent
del305v1
Submit a response
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted

Services

Email this article to a friend
Similar articles in this journal
Similar articles in ISI Web of Science
Similar articles in PubMed
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Search for citing articles in:
ISI Web of Science (11)
Request Permissions

Google Scholar

Articles by Margalioth, E.J.
Articles by Eldar-Geva, T.
Search for Related Content

PubMed

PubMed Citation
Articles by Margalioth, E.J.
Articles by Eldar-Geva, T.

Social Bookmarking


What's this?
© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Investigation and treatment of repeatedimplantation failure following IVF-ET

E.J. Margalioth1, A. Ben-Chetrit, M. Gal and T. Eldar-Geva
IVF Unit, Shaare-Zedek Medical Center, Ben Gurion University of the Negev, Jerusalem, Israel
1 To whom correspondence should be addressed at: IVF Unit, Shaare-Zedek Medical Center, PO Box 3235, Jerusalem 91031, Israel. E-mail: ehudmd@hotmail.com
Pregnancy rate following one cycle of IVF and ET can be as high as 60%. But even in the very successful units, some couples fail repeatedly. The causes forrepeated implantation failure (RIF) may be because of reduced endometrial receptivity, embryonic defects or multifactorial causes. Various uterine pathologies, such as thin endometrium, altered expression of adhesive moleculesand immunological factors, may decrease endometrial receptivity, whereas genetic abnormalities of the male or female, sperm defects, embryonic aneuploidy or zona hardening are among the embryonic reasons for failure ofimplantation. Endometriosis and hydrosalpinges may adversely influence both. In this mini review, we discuss the suggested methods for evaluation andtreatment of RIF: repeated hysteroscopy, myomectomy, endometrial stimulation, immunotherapy, preimplantation genetic screening (PGS), assisted hatching, zygote intra-Fallopian transfer (ZIFT), co-culture, blastocyst transfer, cytoplasmic transfer, tailoring stimulation protocols and salpingectomy for hydrosalpinges.

Key words: implantation/IVF failure/IVF treatment/repeated failure

(二)從改善植入的胚胎著手:
(1)胚胎植入前的胚胎切片檢查:著床失敗的胚胎有很大部份是由於胚胎本身染色體異常引起,雖然這些胚胎在植入前外觀及生長速度都正常。如果在植出前取出胚胎中的一個或兩個細胞做檢查,然後只植入正常的胚胎會增加胚胎著床率。但是有的研究指出胚胎植入前切片篩檢並不會增加試管嬰兒助孕的懷

沒有留言:

博元婦產科不孕症試管嬰兒中心:蔡鋒博醫師,陳昭雯醫師

博元婦產科不孕症試管嬰兒中心:蔡鋒博醫師,陳昭雯醫師

博元婦產科不孕症試管嬰兒中心:蔡鋒博醫師,陳昭雯醫師
Powered By Blogger

博元婦產科不孕症試管嬰兒中心:蔡鋒博醫師,陳昭雯醫師

博元婦產科不孕症試管嬰兒中心:蔡鋒博醫師,陳昭雯醫師

Plurk

追蹤者

標籤

Powered By Blogger

博元婦產科不孕症試管嬰兒中心--蔡鋒博醫師&陳昭雯醫師

博元婦產科不孕症試管嬰兒中心--蔡鋒博醫師&陳昭雯醫師 網址http://www.babymaker.com.tw 地址:500彰化市中正路1段392號 Address:500; 392 Zhong Zheng Road ,Sec.1 ,Chang-Hua ,Taiwan 電話:04-7260678;047260988;0911905889 Fax: 04-7225626 e-mail:yes@babymaker.com.tw; 7260678@gmail.com;ok7260678@gmail.com 蔡院長門診表 :週一至週五下午、晚上&      週六全天 陳副院長門診表:週一至週五早上 掛號專線:04-7260678 (ext:111) 博元Google Maps地圖-----http://maps.google.com/maps/ms?ie=UTF8&hl=zh-TW&msa=0&msid=118241172218343474730.00000112a1cfed19bdfa9&ll=24.083396,120.542915&spn=0.007562,0.013325&z=16&om=1 您搭高鐵怎麼到博元婦產科?? ? http://www.youtube.com/ep.swf?id=76973F126502AA66&eurl= 開車怎麼走到博元???http://www.youtube.com/watch?v=VV-nr4WeWuY 坐火車到博元怎麼走?http://myvlog.im.tv/?id=257365&mid=258867 如妳有問題,在此留言,蔡醫師6小時內親自回覆!!!!http://www.babymaker.com.tw/guestbook/board.asp?board=C&channelid=A36&baseid=A24

http://www.babymaker.com.tw

http://www.babymaker.com.tw

http://www.babymaker.com.tw
http://www.babymaker.com.tw

博元婦產科不孕症試管嬰兒中心--蔡鋒博醫師&陳昭雯醫師

網誌存檔

博元婦產科不孕症試管嬰兒中心--蔡鋒博醫師&陳昭雯醫師